# Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt

> **NCT04816942** · PHASE3 · COMPLETED · sponsor: **Ministry of Health and Population, Egypt** · enrollment: 102 (actual)

## Conditions studied

- Convalescent Plasma
- Covid19
- Immunoglobulins
- Plasma
- Egypt

## Interventions

- **BIOLOGICAL:** Convalescent Plasma

## Key facts

- **NCT ID:** NCT04816942
- **Lead sponsor:** Ministry of Health and Population, Egypt
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-23
- **Primary completion:** 2020-07-21
- **Final completion:** 2020-10-12
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2021-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04816942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04816942, "Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04816942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*